MCID: RNV001
MIFTS: 49

Renovascular Hypertension malady

Category: Cardiovascular diseases

Aliases & Classifications for Renovascular Hypertension

About this section

Aliases & Descriptions for Renovascular Hypertension:

Name: Renovascular Hypertension 10 12
Hypertension, Renovascular 36 65
 
Hypertension Renovascular 47

Classifications:



External Ids:

Disease Ontology10 DOID:1591
ICD1027 I15.0
MeSH36 D006978
NCIt42 C85044
UMLS65 C0020545

Summaries for Renovascular Hypertension

About this section
Wikipedia:68 Renovascular hypertension (or \"renal hypertension\") is a condition in which high blood pressure is... more...

MalaCards based summary: Renovascular Hypertension, also known as hypertension, renovascular, is related to antiphospholipid syndrome and malignant renovascular hypertension. An important gene associated with Renovascular Hypertension is REN (Renin), and among its related pathways are Renin secretion and Peptide hormone metabolism. The drugs fenoldopam and fenoldopam mesylate have been mentioned in the context of this disorder. Affiliated tissues include kidney, heart and endothelial, and related mouse phenotypes are muscle and renal/urinary system.

Related Diseases for Renovascular Hypertension

About this section

Diseases in the Renovascular Hypertension family:

Benign Renovascular Hypertension Malignant Renovascular Hypertension

Diseases related to Renovascular Hypertension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 165)
idRelated DiseaseScoreTop Affiliating Genes
1antiphospholipid syndrome28.8ACE, AGTR1
2malignant renovascular hypertension12.3
3benign renovascular hypertension12.2
4hyposmia nasal hypoplasia hypogonadism10.7ACE, REN
5kidney cortex necrosis10.7ACE, REN
6atrial septal defect 7, with or without av conduction defects10.6ACE, REN
7malignant hypertension10.6ACE, REN
8glomus tympanicum tumor10.6ACE, NPPA
9malignant secondary hypertension10.6EDN1, REN
10pulmonary blastoma10.6ACE, NPPA
11nephrosclerosis10.6
12panophthalmitis10.6EDN1, REN
13acute allergic mucoid otitis media10.5EDN1, REN
14specific bursitis often of occupational origin10.5ACE, REN
15acute diffuse nephritis10.5EDN1, NPPA
16subclavian artery aneurysm10.5ACE, NF1
17chronic end-stage hepatitis c10.5NPPB, REN
18acrodermatitis10.4EDN1, REN
19mitral valve insufficiency10.4NPPB, REN
20pompholyx10.4NPPA, NPPB
21leptomeningeal amyloidosis10.4NPPA, NPPB
22endotheliitis10.4
23acute leukemia10.4NPPA, REN
24hypochromic microcytic anemia with iron overload10.4ACE, NPPA, REN
25partial optic atrophy10.4ACE, REN
26gastric liposarcoma10.4ACE, NPPB
27duane retraction syndrome10.4HMOX1, NPPA
28congenital chloride diarrhea10.4ACE, NPPB
29fibromuscular dysplasia10.4
30purpura simplex10.3ACE, NPPA, REN
31congenital epstein-barr virus infection10.3EDN1, NPPB
32facial nerve disease10.3NPPA, NPPB
33lethal congenital contractural syndrome 210.3EDN1, NPPB
34dominant beta-thalassemia10.3EDN1, NPPA, REN
35periampullary adenoma10.3ACE, EDN1, REN
36horner's syndrome10.2NPPA, NPPB
37aneurysm10.2
38liver lymphoma10.2EDN1, HMOX1
39prostate squamous cell carcinoma10.2ACE, NPPB
40neurofibromatosis10.2
41liver disease10.2EDN1, NPPA, REN
42takayasu's arteritis10.2
43ischemia10.2
44septal myocardial infarction10.2ACE, NPPA, NPPB
45syngap1-related non-syndromic intellectual disability10.2ACE, NPPA, NPPB
46oral mucosa leukoplakia10.1ACE, NPPA, NPPB
47adams-oliver syndrome 510.1ACE, NPPB
48hemangioma10.1ACE, NPPA, NPPB
49ceroid lipofuscinosis, neuronal, 610.1ACE, NPPA, NPPB
50posterior valve urethra10.1ACE, AGTR1

Graphical network of the top 20 diseases related to Renovascular Hypertension:



Diseases related to renovascular hypertension

Symptoms for Renovascular Hypertension

About this section

Drugs & Therapeutics for Renovascular Hypertension

About this section

Drugs for Renovascular Hypertension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 32)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Antihypertensive AgentsPhase 4, Phase 33618
2Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 41804
3
CandesartanapprovedPhase 3149139481-59-72541
Synonyms:
139481-59-7
2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid
2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid
2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl}-1H-benzimidazole-7-carboxylic acid
2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid
2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole
AC-203
AC1L1DWT
Amias
Atacand
Atacand, Blopress, Amias, Ratacand,Candesartan
BIDD:GT0350
Blopress
Blopress (TN)
C07468
C081643
C24H20N6O3
CHEBI:216848
CHEBI:3347
 
CHEMBL1016
CID2541
CV 11974
CV-11974
CV11974
Candesartan
Candesartan (USAN/INN)
Candesartan Cilexetil
Candesartan [BAN]
Candesartan [USAN:INN]
Candesartan cilexetil
D00522
DB00796
FT-0083585
HMS2089M22
HSDB 7520
I01-0374
KS-5003
L000156
LS-32740
MolPort-003-845-570
MolPort-005-943-739
NCGC00167474-01
Ratacand
S1578_Selleck
TL8000897
UNII-S8Q36MD2XX
candesartan
4Amlodipine, atorvastatin drug combinationPhase 317
5
Candesartan cilexetilPhase 3149145040-37-52540
Synonyms:
(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate
1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate
145040-37-5
1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester
2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester
2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe
AC-204
AC1L1DWQ
ATACAND HCT
Almirall brand of candesartan cilexetil
Amias
Astra brand of candesartan cilexetil
AstraZeneca brand of candesartan cilexetil
Atacand
Atacand (TN)
BRD-A65671304-001-02-6
BSPBio_002691
C07709
C077793
C33H34N6O6
CHEBI:216349
CHEMBL1014
CID2540
Candesartan cilexetil
Candesartan cilexetil (JAN/USAN)
Candesartan cilexetil [USAN]
Candesartan hexetil
D00626
FT-0082579
H212/91
 
HMS1922J09
HMS2093E20
I06-0090
KBio2_002187
KBio2_004755
KBio2_007323
KBio3_001911
KBioGR_001607
KBioSS_002187
Kenzen
L006257
LS-32741
MolPort-003-666-552
NCGC00095123-01
NCGC00095123-02
NCGC00095123-03
Parapres
Promed brand of candesartan cilexetil
Racanda
SPBio_000349
SPECTRUM1504261
ST51052687
Spectrum2_000485
Spectrum3_000996
Spectrum4_001124
Spectrum5_001462
Spectrum_001707
TCV 116
TCV-116
TL8000995
Takeda brand of candesartan cilexetil
UNII-R85M2X0D68
candesartan cilexitil
6
Spironolactoneapproved1591952-01-7, 52-01-75833
Synonyms:
4-18-00-01601 (Beilstein Handbook Reference)
4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate
496916-40-6
52-01-7
7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone
7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone
AB00513806
AC-4214
AC1L1L8Q
Abbolactone
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone (TN)
Aldactone A
Alderon
Aldopur
Almatol
Alphapharm Brand of Spironolactone
Alpharma Brand of Spironolactone
Alter Brand of Spironolactone
Altex
Aquareduct
Ashbourne Brand of Spironolactone
Azupharma Brand of Spironolactone
BIDD:PXR0071
BPBio1_000194
BRD-K90027355-001-03-4
BRN 0057767
BSPBio_000176
C07310
C24H32O4S
CHEBI:428201
CHEBI:45692
CHEBI:9241
CHEMBL1393
CID5833
CPD000471892
Cardel Brand of Spironolactone
D00443
D013148
DB00421
Deverol
Dexo Brand of Spironolactone
Diatensec
Dira
Duraspiron
EINECS 200-133-6
Espironolactona
Espironolactona Alter
Espironolactona Mundogen
Espironolactona [INN-Spanish]
Euteberol
Flumach
Frumikal
Generosan Brand of Spironolactone
HMS1568I18
HMS2090N21
HSDB 3184
Hormosan Brand of Spironolactone
I06-1970
Jenapharm Brand of Spironolactone
Jenaspiron
LS-118614
LT00772287
Lacalmin
Lacdene
Laractone
MLS001074672
MLS001333253
MLS001333254
MLS002153245
MLS002207058
Mayoly-Spindler Brand of Spironolactone
Melarcon
Merck dura Brand of Spironolactone
Mundogen Brand of Spironolactone
NCGC00164397-01
 
NCGC00164397-02
NSC 150399
NSC150399
Nefurofan
Novo Spiroton
Novo-Spiroton
NovoSpiroton
Novopharm Brand of Spironolactone
Osyrol
Pfizer Brand of Spironolactone
Pharmafrid Brand of Spironolactone
Practon
Prestwick0_000128
Prestwick1_000128
Prestwick2_000128
Prestwick3_000128
Roche Brand of Spironolactone
S0260
S3378_SIGMA
SAM002264648
SC 9420
SC-9420
SC9420
SMR000471892
SNL
SPBio_002115
Sagisal
Searle Brand of Spironolactone
Sincomen
Spiractin
Spiresis
Spiretic
Spiridon
Spiro L.U.T.
Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)
Spiro-Tablinen
Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]
Spirobeta
Spiroctan
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono Isis
Spirono-Isis
Spironocompren
Spironolactone
Spironolactone (JP15/USP/INN)
Spironolactone A
Spironolactone [BAN:INN:JAN]
Spironolactone [INN:BAN:JAN]
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
Sprioderm
Supra-puren
Suracton
UNII-27O7W4T232
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ
Worwag Brand of Spironolactone
Xenalon
ZINC03861599
betapharm Brand of Spironolactone
ct Arzneimittel Brand of Spironolactone
ct-Arzneimittel Brand of Spironolactone
spiro von ct
spironolactone
spironolattone
von ct, spiro
7
Amilorideapproved452016-88-816231
Synonyms:
17440-83-4 (hydrochloride)
1f5l
2016-88-8 (anhydrous hydrochloride)
2609-46-3
3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide
3,5-Diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide
3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide
3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide
AB00053415
AC-13631
AC1L27IZ
AC1Q3POC
AMILORIDE
AMILORIDE (SEE ALSO: AMILORIDE HCL (2016-88-8))
Amiclaran
Amiclaran (TN)
Amikal (Hydrochloride dihydrate)
Amilorid
Amilorida
Amilorida [INN-Spanish]
Amiloride
Amiloride (INN)
Amiloride HCL
Amiloride Hydrochloride
Amiloride [INN:BAN]
Amiloride hydrochloride hydrate
Amiloridum
Amiloridum [INN-Latin]
Amipramidin
Amipramidine
Amipramizid
Amipramizide
Amiprazidine
Amyloride
BCBcMAP01_000101
BIDD:GT0466
BPBio1_000015
BRD-K97181089-003-02-3
BRD-K97181089-310-03-0
BSPBio_000013
BSPBio_001572
BSPBio_001826
Bio1_000359
Bio1_000848
Bio1_001337
Bio2_000292
Bio2_000772
C06821
C6H8ClN7O
CCRIS 6545
CHEBI:2639
CHEMBL945
CID16231
CPD-10324
D07447
DB00594
Diurex
DivK1c_000182
 
EINECS 220-024-7
Guanamprazin
Guanamprazine
HMS1791O14
HMS1989O14
HMS2089H05
IDI1_000182
IDI1_034042
KBio1_000182
KBio2_000292
KBio2_000394
KBio2_002860
KBio2_002962
KBio2_005428
KBio2_005530
KBio3_000583
KBio3_000584
KBio3_001326
KBioGR_000292
KBioGR_000544
KBioSS_000292
KBioSS_000394
LS-1094
Lopac-A-7410
Lopac0_000111
MK-870 (Hydrochloride dihydrate)
MLS000758249
MLS001060798
Midamor
Midamor (Hydrochloride dihydrate)
MolPort-005-934-472
MolPort-005-937-651
N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide
N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid
NCGC00015089-01
NCGC00015089-02
NCGC00015089-12
NCGC00024443-02
NCGC00024443-05
NCGC00024443-06
NCGC00024443-07
NCGC00024443-09
NINDS_000182
Prestwick0_000007
Prestwick1_000007
Prestwick2_000007
Prestwick3_000007
Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-, monohydrochloride
SMR000449325
SMR000486264
SPBio_000136
SPBio_001934
ST079279
Spectrum2_000118
Spectrum3_000293
Spectrum4_000132
Spectrum5_000776
Spectrum_000034
Tocris-0890
UNII-7DZO8EB0Z3
ZINC04340269
8
Lidocaineapproved1103137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
╬▒-diethylamino-2,6-dimethylacetanilide
9
Heparinapproved, investigational7199005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
10Natriuretic Agents1403
11Mineralocorticoids301
12Contraceptives, Oral3734
13Contraceptive Agents1706
14Sodium Channel Blockers1180
15Diuretics, Potassium Sparing1445
16diuretics1194
17Epithelial Sodium Channel Blockers40
18Hormone Antagonists10002
19Hormones, Hormone Substitutes, and Hormone Antagonists9988
20Hormones11748
21Mineralocorticoid Receptor Antagonists284
22Pharmaceutical Solutions7004
23Calcium, Dietary4678
24calcium channel blockers1743
25Adrenergic beta-Antagonists979
26Anesthetics7385
27Angiotensin-Converting Enzyme Inhibitors634
28Angiotensin Receptor Antagonists1039
29Anticholesteremic Agents1732
30Anesthetics, Local2347
31calcium heparin719
32Fibrinolytic Agents1567

Interventional clinical trials:

(show all 18)
idNameStatusNCT IDPhase
1Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic NephropathyActive, not recruitingNCT01023373Phase 4
2Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic LesionsCompletedNCT00081731Phase 3
3Renal Stenting With Distal Atheroembolic ProtectionRecruitingNCT00868972Phase 2, Phase 3
4Study to Assess the Effects of Intravenous Bendavia in Patients Undergoing Percutaneous Transluminal Angioplasty of the Renal Artery (PTRA)RecruitingNCT01755858Phase 1, Phase 2
5MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal ArteryCompletedNCT00027469Phase 1
6Hypoxia and Inflammatory Injury in Human Renovascular HypertensionRecruitingNCT02266394Phase 1
7MSC for Occlusive Disease of the KidneyActive, not recruitingNCT01840540Phase 1
8Magnetic Resonance Imaging for Evaluating Kidney FunctionCompletedNCT00006173
9Renal Atherosclerotic Revascularization Evaluation: RAVE StudyCompletedNCT00127738
10REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable StentCompletedNCT00631540
11The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular VariablesCompletedNCT01195805
12Telehealth & Remote Measurement Technologies to Improve Medication Adherence in HypertensionCompletedNCT01439256
13A Prospective Danish National Registry of PTRA in Patients With Renovascular HypertensionRecruitingNCT02770066
14Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant HypertensionRecruitingNCT01673373
15Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS)RecruitingNCT02388139
16IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioNRecruitingNCT01705080
17A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF RecurrenceRecruitingNCT01907828
18Evaluation of Patients With Heart Disease Not Eligible for Research ProtocolsRecruitingNCT00001458

Search NIH Clinical Center for Renovascular Hypertension

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: hypertension, renovascular

Genetic Tests for Renovascular Hypertension

About this section

Anatomical Context for Renovascular Hypertension

About this section

MalaCards organs/tissues related to Renovascular Hypertension:

33
Kidney, Heart, Endothelial, Brain, Liver, Lung, Prostate

Animal Models for Renovascular Hypertension or affiliated genes

About this section

MGI Mouse Phenotypes related to Renovascular Hypertension:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.0ADM, EDN1, HMOX1, NF1, NPPA, REN
2MP:00053677.3ACE, ADM, AGTR1, EDN1, HMOX1, NF1
3MP:00053767.2ACE, ADM, AGTR1, EDN1, HMOX1, NF1
4MP:00053877.1ACE, ADM, AGTR1, CMA1, HMOX1, NF1
5MP:00053857.0ACE, ADM, AGTR1, EDN1, HMOX1, NF1
6MP:00053977.0ACE, ADM, AGTR1, CMA1, HMOX1, NF1

Publications for Renovascular Hypertension

About this section

Articles related to Renovascular Hypertension:

(show top 50)    (show all 630)
idTitleAuthorsYear
1
Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results. (26730842)
2016
2
The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension. (25816715)
2015
3
Detection of Segmental Renal Ischemia by Diffusion-Weighted Magnetic Resonance Imaging: Clinical Utility for Diagnosis of Renovascular Hypertension. (26360321)
2015
4
Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model. (25740291)
2015
5
Attenuated muscle metaboreflex-induced pressor response during postexercise muscle ischemia in renovascular hypertension. (25632024)
2015
6
Sympathoactivation and rho-kinase-dependent baroreflex function in experimental renovascular hypertension with reduced kidney mass. (24946879)
2014
7
Renovascular hypertension: A report of 21 cases. (24434389)
2014
8
Renovascular hypertension: is there still a role for stent revascularization? (23917028)
2013
9
Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-I^ and MMPs, and decreases vascular remodeling in renovascular hypertension. (23806385)
2013
10
The Case: An unusual cause of renovascular hypertension. (19444276)
2009
11
Percutaneous balloon angioplasty of renovascular hypertension in pediatric cases. (19241923)
2008
12
Angiographic and intravascular ultrasound assessment of immediate and 9-month efficacy of percutaneous transluminal renal artery balloon angioplasty with subsequent brachytherapy in patients with renovascular hypertension. (18772602)
2008
13
Induction of heme oxygenase-1 in renovascular hypertension is associated with inhibition of apoptosis. (17531161)
2007
14
Diagnosis and management of renovascular disease and renovascular hypertension. (17485974)
2007
15
A successful therapy of renovascular hypertension. (17051904)
2006
16
Diagnostic and treatment of renovascular hypertension in the patient with horseshoe kidney]. (15909888)
2005
17
Where do we stand with renovascular hypertension? (15855217)
2005
18
Effects of chronic quercetin treatment in experimental renovascular hypertension. (15792364)
2005
19
Congenital solitary kidney with renovascular hypertension diagnosed by means of captopril-enhanced renography and magnetic resonance angiography. (15876820)
2005
20
Should renal vein catheterization for selective renin determination be performed in patients with suspected renovascular hypertension?]. (15515466)
2004
21
Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. (15372104)
2004
22
Renal artery stenosis and a functioning hilar paraganglioma: a rare cause of renovascular hypertension--a case report. (15306959)
2004
23
Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension. (12591015)
2003
24
Renovascular hypertension, endothelial function, and oxidative stress. (12421899)
2002
25
Reduced spontaneous baroreceptor sensitivity in patients with renovascular hypertension. (11791033)
2002
26
Diagnostic criteria for renovascular hypertension. (12136534)
2002
27
Anti-hypertensive effect of water extract of danshen on renovascular hypertension through inhibition of the renin angiotensin system. (12067101)
2002
28
Increased oxidative stress in experimental renovascular hypertension. (11230332)
2001
29
Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. (11422751)
2001
30
Angiotensin converting-like enzymes from urine of untreated renovascular hypertensive and normal patients: purification and characterization. (10741903)
2000
31
Tuberculous abdominal lymphadenopathy causing reversible renovascular hypertension. (11273151)
2000
32
Evaluation and long-term outcome of pediatric renovascular hypertension. (10975320)
2000
33
Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. (10406830)
1999
34
Renovascular hypertension and prolonged encephalopathy associated with moyamoya disease. (10206139)
1999
35
Mesangial hyperplasia in a patient with renovascular hypertension and proteinuria. (9794597)
1998
36
Level of vasopressin in renal venous blood of patients with renovascular hypertension due to unilateral stenosis of renal arteries]. (9333766)
1997
37
A comparison of outcome criteria in the diagnosis of renovascular hypertension. (8989973)
1996
38
Role of captopril renography in the diagnosis of renovascular hypertension. (8768915)
1996
39
Diagnosis of renovascular hypertension: feasibility of captopril-sensitized dynamic MR imaging and comparison with captopril scintigraphy. (8610560)
1996
40
Diagnosis of renovascular hypertension: are i.v. digital subtraction angiography and the excretory urograms really outdated compared to captopril renography? (8966007)
1996
41
Renography in renovascular hypertension. (8879858)
1996
42
Diagnosis of renovascular hypertension by echo-Doppler velocimetry. (8840548)
1996
43
Increased nitric oxide activity in early renovascular hypertension. (8769793)
1996
44
Pediatric renovascular hypertension. (8723806)
1996
45
A case of renovascular hypertension with marked polyuria after percutaneous transluminal renal angioplasty. (8742962)
1996
46
Increased vascular collagen and noncollagenous protein synthesis contributes to sustain chronic phase of two-kidney, one-clip renovascular hypertension. (8709342)
1996
47
Renal effects of antihypertensive agents in parenchymal renal disease and renovascular hypertension. (1382165)
1992
48
Aspirin injection test to predict angioplasty outcome in unilateral renovascular hypertension: preliminary report. (1838974)
1991
49
The role of laboratory testing in the diagnosis of renovascular hypertension. (1914198)
1991
50
Control of malignant renovascular hypertension by percutaneous transluminal angioplasty and therapeutic renal embolization. (6767370)
1980

Variations for Renovascular Hypertension

About this section

Expression for genes affiliated with Renovascular Hypertension

About this section
Search GEO for disease gene expression data for Renovascular Hypertension.

Pathways for genes affiliated with Renovascular Hypertension

About this section

GO Terms for genes affiliated with Renovascular Hypertension

About this section

Biological processes related to Renovascular Hypertension according to GeneCards Suite gene sharing:

(show all 21)
idNameGO IDScoreTop Affiliating Genes
1cellular response to drugGO:003569010.2EDN1, REN
2regulation of MAPK cascadeGO:004340810.2NF1, REN
3phosphatidylinositol 3-kinase signalingGO:001406510.2EDN1, NF1
4response to muscle stretchGO:003599410.1EDN1, NPPA
5regulation of angiogenesisGO:004576510.1HMOX1, NF1
6regulation of blood pressureGO:000821710.1EDN1, HMOX1
7response to insulinGO:003286810.0ADM, NPPA
8receptor guanylyl cyclase signaling pathwayGO:000716810.0NPPA, NPPB
9cGMP biosynthetic processGO:000618210.0NPPA, NPPB
10positive regulation of smooth muscle cell proliferationGO:00486619.9EDN1, HMOX1
11positive regulation of urine volumeGO:00358109.8EDN1, NPPB
12positive regulation of vasodilationGO:00459099.8ADM, HMOX1
13negative regulation of angiogenesisGO:00165259.7NF1, NPPB
14response to nicotineGO:00350949.7EDN1, HMOX1
15calcium-mediated signalingGO:00197229.4AGTR1, EDN1
16positive regulation of heart rateGO:00104609.4ADM, EDN1, NPPA
17regulation of vasoconstrictionGO:00192299.3ACE, AGTR1
18response to lipopolysaccharideGO:00324969.3ADM, EDN1, REN
19negative regulation of cell proliferationGO:00082859.3ADM, HMOX1, NF1
20cellular protein metabolic processGO:00442679.0ACE, CMA1, NPPA, REN
21response to hypoxiaGO:00016668.3ADM, EDN1, HMOX1, NF1, NPPA

Sources for Renovascular Hypertension

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet